MedTrace Logo

The Leaky Lung Test

NCT02306473 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-01-04

No results posted yet for this study

Summary

This is a clinical trial designed to test the hypothesis that measuring the absorption and excretion of inhaled mannitol will provide a clinically useful marker of airway epithelial permeability in asthma.

Conditions

  • Asthma
  • Allergy
  • Reactive Airway Disease
  • Lung Diseases, Obstructive

Interventions

DRUG

Mannitol

Subjects will be challenged with inhaled mannitol according to already approved protocols.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Syntara

    collaborator INDUSTRY

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Rochester

    lead OTHER

Principal Investigators

  • Steve N Georas, M.D. · University of Rochester

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-12-01
Completion
2017-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02306473 on ClinicalTrials.gov